We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$38.8B
AUM Growth
+$957M
Cap. Flow
+$1.75B
Cap. Flow %
4.52%
Top 10 Hldgs %
18.92%
Holding
4,122
New
310
Increased
2,005
Reduced
1,517
Closed
198

Sector Composition

Rank Sector Weight
1 Technology 11.12%
2 Financials 4.47%
3 Industrials 3.2%
4 Consumer Discretionary 3.13%
5 Communication Services 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRX icon
3901
TRX Gold Corp
TRX
$360M
$16K ﹤0.01%
+10,982
New +$16.2K
MAIA icon
3902
MAIA Biotechnology
MAIA
$83.9M
$15K ﹤0.01%
10,620
GOSS icon
3903
Gossamer Bio
GOSS
$86.8M
$14K ﹤0.01%
42,800
-34,140
-44% -$53.7K
BLNK icon
3904
Blink Charging
BLNK
$85.6M
$13K ﹤0.01%
22,483
-2,219
-9% -$1.56K
PRPL icon
3905
Purple Innovation
PRPL
$28.4M
$13K ﹤0.01%
793
TRIB
3906
Trinity Biotech
TRIB
$7.86M
$12K ﹤0.01%
743
MYND
3907
Mynd.ai
MYND
$18.4M
$11K ﹤0.01%
30,000
SES icon
3908
SES AI
SES
$211M
$11K ﹤0.01%
11,773
-1,850
-14% -$3.14K
ONCY
3909
Oncolytics Biotech
ONCY
$98.3M
$9K ﹤0.01%
+10,771
New +$10.7K
SGMO
3910
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$9K ﹤0.01%
38,017
+4,200
+12% +$1.67K
UAVS icon
3911
AgEagle Aerial Systems
UAVS
$55.5M
$9K ﹤0.01%
10,000
INVZ icon
3912
Innoviz Technologies
INVZ
$114M
$7K ﹤0.01%
10,339
-8,365
-45% -$7.64K
CUE icon
3913
Cue Biopharma
CUE
$128M
$5K ﹤0.01%
667
ZONE
3914
CleanCore Solutions
ZONE
$32.4M
$4K ﹤0.01%
11,400
GAB.RT
3915
DELISTED
The Gabelli Equity Trust Rights (expiring April 14 2026)
GAB.RT
$4K ﹤0.01%
+550,570
New +$5.51K
CNSY
3916
Cerenome, Inc. Common Stock
CNSY
$25.5M
$2K ﹤0.01%
538
QNCX icon
3917
Quince Therapeutics
QNCX
$31.8M
$2K ﹤0.01%
76
RVSNW icon
3918
Rail Vision Ltd Warrant
RVSNW
$721K
$2K ﹤0.01%
58,490
-74,290
-56% -$4.07K
BUI.RT
3919
DELISTED
BlackRock Utilities, Infrastructure & Power Opportunities Trust Rights (expiring April 2, 2026)
BUI.RT
$1K ﹤0.01%
+91,907
New +$1.65K
ABSI icon
3920
Absci
ABSI
$1.61B
-12,875
Closed -$45K
ACMR icon
3921
ACM Research
ACMR
$5.66B
-7,176
Closed -$283K
AFG icon
3922
American Financial Group
AFG
$12B
-1,605
Closed -$219K
AGGY icon
3923
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$923M
-4,812
Closed -$212K
AGQI icon
3924
First Trust Active Global Quality Income ETF
AGQI
$56.1M
-10,026
Closed -$165K
AGYS icon
3925
Agilysys
AGYS
$3.03B
-2,511
Closed -$298K

Similar funds

Cambridge Investment Research Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Cambridge Investment Research Advisors held 4,122 positions worth $38.8B, up 2.5% from $37.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors deployed $1.75B of net new capital in Q1 2026, opening 310 new positions and adding to 2,005 existing holdings. Its largest new stake was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $35.4M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2026 buy was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.
  • Cambridge Investment Research Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $140M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $35.4M.
  • Cambridge Investment Research Advisors fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2026, selling an estimated $7.82M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $38.8B portfolio in Q1 2026.
  • Cambridge Investment Research Advisors opened 310 new positions and closed 198 in Q1 2026.
  • Cambridge Investment Research Advisors's portfolio value rose 2.5% quarter-over-quarter to $38.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.